In the coming weeks, Speaker Nancy Pelosi’s (D-Calif.) priority drug pricing bill, H.R. 3, is expected to come up for a vote in the House of Representatives. Make no mistake -- this is a socialist piece of legislation. Unfortunately, with the way the Democratic Party is trending and its major candidates for the presidency in 2020 endorsing increasingly big-government policies, H.R. 3 is almost guaranteed to pass the chamber.